Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Drought-responsive element-binding proteins (DREBs) are a major class of transcription factors in plants that play a critical role in the response to abiotic stresses, particularly drought, salinity, and low temperature. They belong to the APETALA2/Ethylene-Responsive Factor (AP2/ERF) family and specifically bind to the dehydration-responsive element (DRE) or C-repeat (CRT) cis-acting elements in the promoters of stress-inducible genes. While they are essential for plant adaptation to environmental stress and are primary targets for agricultural biotechnology to improve crop resilience, they are not considered therapeutic targets in human medicine. In the context of drug discovery, the term is often a misnomer or may be confused with the human Core-binding factor (CBF), which is a transcription factor involved in hematopoiesis and a known target in leukemia. There are no known drugs or clinical applications for DREB proteins in humans.
Not applicable for human therapeutics
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Drought-responsive element-binding protein (DREB) (DREB).